Activation of RyR2 by class I kinase inhibitors. - Chakraborty, A D; Gonano, L A; Munro, M L; Smith, L J; Thekkedam, C; Staudacher, V; Gamble, A B; Macquaide, N; Dulhunty, A F; Jones, P P (British Journal of Pharmacology, 2019)